Manufacturers are required to adjust their prices to align with this new ceiling, plus any applicable Goods and Services Tax (GST). If a manufacturer’s current price is below the revised ceiling, they should maintain it. They must update their price lists and submit them to the NPPA and relevant authorities. Retailers must display the updated prices prominently. Non-compliance will result in penalties and potential financial liabilities. This order supersedes any previous pricing directives for the drug.